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1 Introduction 
1.1 Anatomy of the prostate gland 
Mouse prostate consists out of four different lobes: the dorsal and lateral lobe 
originates dorsally at the base of seminal vesicles bilaterally and partly wrap 
bilaterally around the ventral urethra. Ventral prostate lobe, originates ventrally and 
wraps incompletely around the urethra dorsally. Fourth lobe is the anterior lobe 
located to the slighter curvature of the seminal vesicles.  
Human prostate consists out of three zones: First, the central zone that encircles 
ejaculatory ducts and terminates in prostatic urethra. The peripheral zone is 
surrounding the transitional zone and the central zone. Third lope is the transitional 
zone surrounding the proximal urethra1 (Fig.1). 
 
Figure 1: Comparison of a mouse and human prostate. Taken from: Ahmad, I., Sansom, O.J. & 
Leung, H.Y. Advances in mouse models of prostate cancer. Expert Rev Mol Med 10, e16. 
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1.2 Prostate cancer  
Besides lung and colon cancer, prostate cancer is the most common death cause in 
man all over the world. Although there is a variety of research done in this field, the 
prevention and treatment of this cancer type is a medical challenge. Progression of 
this cancer type, as well as other cancer types, depends on genetic and epigenetic 
changes resulting from mutated or inactivated tumor suppressor genes and the 
activation of oncogenes2,3. It is assumed that there is a huge number of additional 
factors involved in prostate cancer progression, like hormonal changes and 
environmental factors like physical trauma and probably dietary habits4. Interestingly 
the risk of prostate cancer seems to underlie a geographic variation: For example 
men in South East Asian countries have the lowest incidence of prostate cancer, 
while men from Western countries have a much higher tendency to get this disease. 
It has been shown that men from South East Asian countries after migration to 
western countries develop higher prostate cancer risks within one generation5, 
arguing as well for a strong environmental component. Moreover epidemiological, 
histopathological and molecular pathological studies hypothesize that inflammation 
plays an important role in developing this disease having a tumor-promoting effect6. 
Although there is a lot of research in this field, the relationship between inflammation 
and prostate cancer is not completely understood and requires further examination to 
define the link between prostate inflammation and cancer.  
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1.3 Inflammation and Prostate cancer 
It was estimated that infections and inflammatory responses are linked to 15-20% of 
all deaths from cancer worldwide7.  
Further it is known that a high number of people that suffer from chronic prostatitis 
have an increased risk to develop prostate cancer at a later age. Cancer progression 
is assumed to start with proliferative inflammatory atrophy [PIA] characterized by 
immune cell infiltration, downregulation of genes important for cell cycle progression 
and upregulation of stress responsive genes. PIA is known to be quite frequently 
merged with high-grade prostatic intraepithelial neoplasia (PIN) characterized by 
genetic instability and accumulation of genetic changes8 and known as the ultimate 
precursor of invasive carcinoma.  
Therefore it is assumed that a permanent inflammation of the prostatic duct is linked 
to a higher risk of prostate cancer. This is underlined by studies showing that 
bacterial infections could be able to promote cancer progression via permanent 
inflammatory stimulation of the prostate. It was shown that mice with a chronic 
Escherichia coli infection, investigated after 5 days, 12 and 26 weeks develop 
inflammatory changes in stromal and epithelial cells already after 12 weeks. 26 
weeks after bacterial infiltration, mouse prostates show a phenotype related to 
prostatic intraepithelial neoplasia and high-grade dysplasia, showing increased signs 
of oxidative DNA damage too. This finding supports the hypothesis of an existing link 
between inflammation and prostate cancer9. Next to infectious agents such as 
bacteria and viruses, urine reflux is assumed to be causative for a permanent 
inflammatory stimulation4. Thereby immunological cascades such as the NFkB 
pathway including its key mediator IkB kinase 2 (IKK2) are triggered. Interestingly it is 
! '!
documented that long time use of aspirin, known as an inhibitor of IKK210, seem to 
decrease prostate cancer risk. Although it is not exactly known what molecular 
processes are involved in the linkage of inflammation and cancer, the NFkB pathway 
and therein the IKK2 kinase seem to be an excellent target for further research.  
1.4 From Proliferative inflammatory atrophy (PIA) to Invasive 
carcinoma 
 
Figure 2: Cellular and molecular model of early prostate neoplasia progression. Taken from: 
De Marzo, A.M., et al. Inflammation in prostate carcinogenesis. Nat Rev Cancer 7, 256-269 
 
Although the exact reasons for development of prostate cancer and how it is linked to 
inflammation are not yet clear, several hypotheses have been put forward 
speculating how inflamed prostate tissue could develop invasive carcinoma. It seems 
that the progression of this disease starts with an infiltration of immune cells such as 
lymphocytes, macrophages and neutrophils stimulated by several factors like 
repeated infections, dietary factors or onset of autoimmunity. These immune cells 
produce cytokines and chemokines promoting further immunological processes. 
Phagocytes release reactive oxygen and nitrogen species causing cell injury followed 
by DNA damage resulting in mutation of genes involved in cell metabolism, 
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proliferation and apoptosis. A complicated interplay of these changes in DNA 
structure is assumed to lead finally to invasive carcinoma formation (Fig.2). 
1.5 Factors linked to inflammation 
As mentioned above environmental factors but also autoimmune reactions seem to 
stimulate and promote inflammation and prostate cancer. Inflammation is a very 
complex process in which many cell types and proteins are involved to interact with 
each other resulting in an increased production of cytokines such as TNF! that 
further activate immune cells, chemokines such as CXCL5, CXCL2, CXCL10 and 
CXCL15 or intercellular adhesion molecules such as ICAM I that attract these cells. 
1.5.1 NFkB pathway 
One major molecular process stimulated within inflammation is the NFkB pathway 
with its key mediator IKK2 kinase (IKK"). IKK2 is part of a heterotrimeric complex 
additionally containing alpha (IKK!) and gamma (IKK#/NEMO) subunits. IKK! and 
IKK2 (IKK") have kinase activity whereas IKK# works as a regulatory subunit. 
Together these proteins play an essential role in the NFkB pathway responsible for 
activation of many factors involved in inflammation and many other physiological 
processes such as cell growth, differentiation, proliferation, cell survival and 
apoptosis. 
1.5.1.1 Molecularbiological background of NFkB pathway 
Initiated by a variety of factors, ligands such as IL1 and TNF! bind to respective 
receptors leading to a cascade of protein interactions that result in the 
phosphorylation and activation of the IKK2 kinase11. Hence IKK2 phosphorylates 
Inhibitor of kappaB (IkB) that is consequently linked to polyubiquitinin chains followed 
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by proteasomal degradation and release of NFkB transcription factor (Fig.3). 
 
Figure 3: An illustration of the inflammatory NFkB pathway. Taken from: Schmid, J.A. & 
Birbach, A. IkappaB kinase beta (IKKbeta/IKK2/IKBKB)--a key molecule in signaling to the 
transcription factor NF-kappaB. Cytokine Growth Factor Rev 19, 157-165 
 
1.6 Tumor suppressor genes 
1.6.1 Phospatase and tensin homolog (PTEN) 
Besides inflammation and a permanent activation of the IkB/IKK2 axis, another 
component assumed to play a role in prostate cancer development is phosphatase 
and tensin homologue PTEN. PTEN mutations or deletions are found in 30% of 
primary prostate cancers12 and in 63% of metastatic prostate tissue samples13 
demonstrating that the tumor suppressor gene PTEN is a quite frequent factor 
involved in prostate cancer development and progression. It is documented that in 
mouse models PTEN deficiency results in transformation of prostate tissue 
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depending on PTEN activity14. Monoallelic deletions of PTEN lead to low grade PIN 
late in mouse life whereas full deletions lead to high grade PIN with ability to form 
invasive and possibly metastasizing carcinomas at a late age15. 
1.6.1.1 Molecular biological background of PTEN 
The main function of PTEN is as a phosphatase causing the dephosphorylation of 
phosphatidylinositol 3,4,5-triphosphate (PIP3) resulting in the biphosphate product 
phosphatidylinositol 4,5-biphosphate (PIP2) and thereby negatively regulating the 
PI3K/AKT pathway16. Loss of PTEN results in accumulation of PIP3 and activation of 
its downstream effectors such as the serine/threonine kinase AKT that is responsible 
for cell cycle progression and cell survival17.  
1.7 Factors that promote invasive tumor formation 
1.7.1 Basal cell layer 
It is documented that malignant glands in prostate adenocarcinoma lack the basal 
cell layer when acquiring an invasive character. Therefore antibodies targeting the 
basal cell marker p63 are quite frequently used for detection of loss of basal cell 
layer18. 
1.7.2 Smooth muscle cells 
Smooth Muscle Actin (SMA) and Smooth Muscle Myosin Heavy Chain (MYH11), the 
main components in smooth muscle cells, are used as differentiation markers in 
prostate cancer. It is known that there is a reduction of smooth muscle correlating 
with the histological grade of prostate tumors and that this tissue is frequently lost in 
malignant tumors15,19. 
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1.7.3 Nkx3.1 and Androgen Receptor 
Nkx3.1 is known as a homeodomain transcription factor that functions as a prostate 
specific tumor suppressor. In mouse models with bacterial prostatitis it was shown 
that the Nkx3.1 level was profoundly reduced in infected prostate lobes20. Loss of 
Nkx3.1 leads to epithelial hyperplasia and dysplasia that worsens with age20. These 
data correlate with findings from human prostate cancer21. Moreover it is 
hypothesized that diminished Nkx3.1 could lead to an abnormal expression of 
antioxidant and peroxidant enzymes leading to an increase in DNA damage that 
consequently promotes neoplastic transformation22. Interestingly it was shown that 
the downregulation of Nkx3.1 correlates with the reduction of the androgen receptor 
(AR) that is assumed to regulate Nkx3.120. This correlation gives an impression of 
how the Nkx3.1 level could be controlled.  
1.7.4 Spink3 
Spink3, homolog of human Spink1 gene, has serin protease inhibitor function and is 
documented to be a biomarker upregulated in a subset of aggressive ETS (E-twenty 
six) negative prostate cancers and assumed to be involved in invasiveness of 
prostate tumors23. 
1.8 Other proteins known to be involved to prostate 
carcinogenesis 
1.8.1 SFRPI/ IV 
Secreted frizzled related proteins are known to be an antagonists of Wnt signalling, a 
pathway that is involved in regulation of cell proliferation, differentiation, apoptosis 
and negatively regulates bone formation24,25. In further research it was shown that 
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SFRPI treatment of prostate cells or tissue leads to increased proliferation, 
decreased apoptosis, and decreased signalling through the Wnt/beta-catenin 
pathway in vitro and increased proliferation in vivo26. Further it was revealed that in 
vitro overexpression of SFRP4 is linked to a decrease in cell proliferation and 
invasiveness 24.  
1.8.2 Hepsin 
Another gene that is documented to be overexpressed in prostate cancer is the 
trypsin-like serine protease Hepsin27. It was reported that Hepsin overexpression in a 
mouse model of nonmetastasizing prostate cancer causes disorganization of the 
basement membrane and promotes primary prostate cancer progression and 
metastasis28. But what cellular and molecular mechanisms are involved therein is still 
unclear and warrants further investigation. 
1.9 Aim of the study 
As mentioned above prostate cancer is the most common cancer type in men all over 
the world. Although this disease is responsible for 10% of death in male population 
possible causes and progression are rather unclear. It has been reported that 
inflammation is a causative invent in 20% of human cancers and there is a growing 
amount of evidence that suggests that inflammation and inflammatory signalling are 
involved in the tumorigenic process of prostate cancer. 
In this study we wanted to demonstrate this link using a genetic model. This model 
harbours a heterozygote deletion of the PTEN gene and expresses a constitutively 
active IKK2 kinase. Probasin–Cre mice expressing CRE recombinase gene under the 
control of a prostate specific promoter were first crossed with mice harbouring an 
inducible IKK2 gene with an upstream loxP-flanked (“floxed”) stop cassette to 
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investigate a permanent inflammatory stimulation in the prostate tissue. Second 
Probasin-Cre mice were crossed with mice carrying a floxed version of the tumor 
suppressor PTEN that is known to be one of the most mutated genes in prostate 
carcinogenesis and documented to cause the late precursor lesion PIN (prostate 
intraepithelial neoplasia). Third we wanted to investigate what consequences the 
combination of both factors might have in the progression of prostate carcinogenesis. 
For this reason we established double transgenic mice harbouring Probasin-Cre 
background, IKK2 gene with an upstream floxed stop cassette and the floxed PTEN 
gene.  
Starting with chip analysis to get an overview of up and down regulated genes we 
used real-time RT PCR, immunoblot analysis and insitu hybridisation technique to 
investigate how inflammation could lead to prostate cancer and which molecular 
processes are involved. 
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2 Methods 
2.1 Mice 
Mouse breeding was performed by the project manager Andreas Birbach creating the 
different mouse models for the project described below. 
2.1.1 Probasin–Cre mice 
Probasin–Cre (PB-Cre4) (Fig.4) mice were obtained from the NCI Fredrick mouse 
repository and express the CRE recombinase specifically in the prostate epithelium. 
The Cre gen is under the control of the composite promoter ARR2PB which is a 
derivative of the rat prostate-specific probasin (PB) promoter29. 
 
Figure 4: CRE recombinase gene under the control of the ARR2PB promotor expressed in 
Probasin-Cre mice. 
2.1.2 Mice with a floxed PTEN allele 
Mice with a floxed PTEN allele15 (Fig.5) were obtained from Prof. Tak Mak (Ontario 
Cancer Institute, Toronto, Canada) via Dr. Gernot Schabbauer (Department of 
Vascular Biology, Medical University of Vienna). Mice with a floxed PTEN allele will 
express less PTEN after crossing with Probasin-Cre mice using the well-described 
CRE-Lox system. 
 
Figure 5: Transgenic gene cassette for CRE-mediated deletion of PTEN !
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2.1.3  R26StoplIKK2 mice 
R26StoplIKK2 (Fig.6) mice were obtained from Dr. Marc Schmidt-Suppran (Max 
Planck institute for Biochemistry, Martinsried, Germany). This strain constitutes a 
mouse model that expresses a constitutively active IKK2 kinase upon excision of 
floxed Stop cassette 30.  
 
Figure 6: Transgenic gene cassette for CRE-mediated expression of IKK2 gene 
2.2 Genotype of mouse models for this project 
Mice were bred on a C57BL/6 background, yielding different genotypes we used for 
our prostate cancer project (Fig.7). In this study the shortcut PE stands for prostate 
epithelium, meaning that the transgene is only expressed in epithelial cells of the 
prostate. 
 
Figure 7: Genetic background of IKK2ca/ca, PE-PTEN+/-(-/-) and PE-PTEN+/-IKK2ca/ca mice 
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2.3 Genomic DNA isolation 
Solutions and Buffer 
Lysis buffer 
 
For verifying the genotype of transgenic mice genomic DNA was isolated from tail 
biopsies. In samples with tail biopsies 500µl lysis buffer, 3µl Proteinase K (20 mg/ml) 
was added and they were incubated at 58°C over night. After adding 200µl 5M NaCl 
and mixing, samples were centrifuged at 16000g at room temperature for 5 min. 
650µl of the supernatants were transferred to a new sample and 650µl Isopropanol 
(concentrated) was added to each sample before centrifugation at 16000g for 30min. 
The supernatants were discarded and 1ml of ice cold 70% ethanol was added and 
samples were again centrifuged at 16000g at 4°C. The pellets were dried for 10 min 
at room temperature and resuspended in 100µl of 10 mM Tris pH8.  
2.4 Genotyping 
2.4.1 Polymerase chain reaction (PCR) 
Solutions and Buffer 
Taq Polymerase (5 units/ microliter) and 10x Buffer (Peq Lab) 
 
For genotyping we added 2.5µl buffer, 0,5 µl dNTPs (10 mM), 0,5µl forward and 
reverse primer (10µM), 0,5µl taqPolymerase and 20µl ddH2O to 1µl template 
solution. 
 
Gene (symbol) or 
amplicon 
Primer sequences (sense and antisense, 5ʼ-> 3ʼ) 
CRE 5'-CGGTCGATGCAACGAGTGATGAGG-3' 
5'-CCAGAGACGGAAATCCAT CGCTCG-3' 
PTEN 5'-CTCCTCTACTCCATTCTTCCC-3' 
5'-ACTCCCACCAATGAACAAAC-3' 
rNeo/IKK2 5'-GAGCTGCAGTGGAGTAGGCG-3' 
5'-GCCTTCTTGACGAGTTCTTC-3' 
ROSA 5'-CCAGATGACTACCTATCCTC-3' 
5'-GAGCTGCAGTGGAGTAGGCG-3' 
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Gene (symbol) or 
amplicon 
Primer sequences (sense and antisense, 5ʼ-> 3ʼ) 
  
PTENex 5'-ACTCCCACCAATGAACAAAC-3' 
5'-GGTAGACTAGTCGGTACTCAG-3' 
Table 1: Primer sequences used for Polymerase chain reaction 
 
Step Temperature/Time Cycle 
 95°C 10min 1 
Denaturation 95°C 30 sec 
Annealing 55°C 30 sec  
Elongation 72°C 1 min 
 
40 
Final Elongation 72°C 5 min 1 
Table 2: Polymerase chain reaction (PCR) cycle periods and temperatures 
2.5 RNA extraction 
 
2.5.1 RNA isolation kit 
Solutions and Buffer 
RNA isolation kit (Qiagen, Hilden) 
Total RNA kit (Peqlab, Erlangen) 
For RNA extraction prostate tissue/cells was homogenized in RNA later using a 
Polytron homogenizer and purified on RNA binding columns using RNA isolation kit 
RNeasy or Total RNA kit. Isolation instructions were used from respective 
manufacturers. 
2.5.2 RNA isolation from cells with TRIZOL 
Solutions and Buffer 
Trizol: Carl Roth GmbH 
Chloroform: Rotipuran$ % 99% p.a. (Carl Roth GmbH) 
The media was removed and cells were washed with 1xPBS before adding 1ml 
TRIZOL per 0,1 -1g cells, transferred to samples and incubated for 5 minutes at 15-
30°C.  After adding 0,2ml of chloroform for each 1ml TRIZOL used in the beginning, 
the samples were vortexed for 15sec and incubated for 2-3 min at 15-30°C. Then the 
samples were centrifuged at no more than 12 000g for 15 min at 2-8°C to get an 
aquatic, an organic and a central protein phase. Aquatic phases, including RNA, 
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were transferred to new tubes, 0,5ml Isopropyl alcohol was added for each 1ml 
TRIZOL that was used in the beginning and incubated at 15-30°C for 10min. After 
incubation samples were centrifuged at no more than 12 000g for 10 min at 2-8°C. 
The supernatants were removed and the pellets were washed with 1ml 75% ethanol 
for each 1ml TRIZOL used in the beginning. Again the samples were centrifuged this 
time at no more than 7 500g for 5 min at 2-8°C. Afterwards the supernatants were 
removed. The pellets were dried for around 5-10min at room temperature and 10µl 
RNAse free ddH2O was added to each sample. 
! ")!
2.6 cDNA synthesis 
Solutions and Buffer 
RevertAid H Minus First standard cDNA synthesis kit (Fermentas, St. Leon-Rot) 
2.7 Real-time RT-PCR 
Solutions and Buffer 
TaqPolymerase (5 units/ microliter) and 10x Buffer (Peqlab) 
DMSO (Sigma) 
SYBR green (Invitrogen) 
 
For real-time RT-PCR we added 2,5µl buffer, 2,375µl DMSO (1:100 dilution), 0,125µl 
SYBR green, 0.5µl dNTPs (10mM), 0,5µl forward and reverse primer (10µM), 0,1µl 
taqPolymerase, 17,5µl ddH2O to 1µl cDNA. 
For amplification we used a StepOne real-time PCR cycler (Applied Biosystems, 
Vienna, Austria). HPRT was used as housekeeping gene. 
Gene (symbol) or 
amplicon 
Primer sequences (sense and antisense, 5ʼ-> 3ʼ) 
CXCL2 GCGCCCAGACAGAAGTCATAG 
AGCCTTGCCTTTGTTCAGTATC 
CXCL5 GAAAGCTAAGCGGAATGCAC 
GGGACAATGGTTTCCCTTTT 
CXCL10 GCTCCTGCATCAGCACCAGC 
CTTGAACGACGACGACTTTGG 
CXCL15 CCA TGG GTG AAG GCT ACT GT 
TCT CAG GTC TCC CAA ATG AAA 
Cytokeratin18 CAGCCAGCGTCTATGCAGG 
CTTTCTCGGTCTGGATTCCAC 
ICAM1 TGC GTT TTG GAG CTA GCG GAC CA 
CGA GGA CCA TAC AGC ACG TGC AG 
TNF TAGCCAGGAGGGAGAACAGA 
TTTTCTGGAGGGAGATGTGG 
SFRP1 CAACGTGGGCTACAAGAAGAT 
GGCCAGTAGAAGCCGAAGAAC 
SFRP4 AGAAGGTCCATACAGTGGGAAG 
GTTACTGCGACTGGTGCGA 
Nkx3.1 ATGCTTAGGGTAGCGGAGC 
TGCGGATTGCCTGAGTGTC 
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Gene (symbol) or 
amplicon 
Primer sequences (sense and antisense, 5ʼ-> 3ʼ) 
Spink3 ATG AAG GTG GCT GTC ATC TTT C 
TCA GCA AGG CCC ACC TTT TCG 
Smooth muscle actin GTCCCAGACATCAGGGAGTAA 
TCGGATACTTCAGCGTCAGGA 
MYH11 AAGCTGCGGCTAGAGGTCA 
CCCTCCCTTTGATGGCTGAG 
HPRT CAA ATC AAA AGT CTG GGG ACG C 
GCT TGC TGG TGA AAA GGA CCT C 
Table 3: List of oligonucleotids used for real-time RT-PCR 
 
Step Temperature/Time Cycle 
 95°C 10min 1 
Denaturation 95°C 15 sec 
Annealing 55°C 15 sec  
Elongation 72°C 1 min 
 
40 
Final Elongation 72°C 5 min 1 
Table 4: Real-time RT PCR cycle periods and temperatures 
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2.8 Tissue sectioning and immunostaining 
2.8.1 Paraffin sections 
Solutions and Buffer 
Xylol substitute: Roticlear$ (Carl Roth) 
Antigen Retrieval Solution: Target Retrieval Solution (Dako) 
10xPBS:  
80g NaCl 
 2g KCl 
14,4g Na2NPO4 
2,4g KH2PO4 
pH 7,4 
& 1000ml with ddH2O 
 
For paraffin sections, harvested tissue was fixed over night in 4% paraformaledhyde. 
After being dehydrated tissues were paraffin-embedded in a small tissue blocks, cut 
in 2µm sections using a Leica microtome and were collected on SuperFrost Plus 
slides (Thermo Scientific, Braunschweig, Germany). 
Paraffin sections were first deparaffinised two times for 20 minutes in xylol substitute 
than rehydrated in descending ethanol solutions (100%, 96%, 80%, 70%, 50%) for 
30 seconds each. Afterwards the slides were incubated for 5 minutes in ddH2O and 
then the antigen retrieval was started using a steamer for simmering the slides in 
antigen retrieval solution for 40min. Slides were cooled down and washed with 
1xPBS.  
2.8.2 Cryosections 
For frozen sections, harvested tissue was directly frozen in isopentane/liquid nitrogen 
and frozen until cutting. Cryosections were cut on a cryostat in 8µm sections, dried at 
room temperature for 20min or longer and processed or stored at -80°C (-20°C if not 
possible otherwise) until needed. Cyosections were incubated in -20°C cold acetone 
at room temperature for another 3min and washed with 1xPBS for 5min. 
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2.9 Immunostaining 
Solutions and Buffer 
Goat serum: 
Avidin/ Biotin blocking kit (Vector laboratories, Burlingame, CA) 
DAB tablets (Sigma) 
Hemalaun (Mayers Hemalaun) 
In Situ Cell Death Detection Kit (Roche, Vienna, Austria) 
 
Tissues were encircled by a DakoPen and incubated in 5% goat blocking serum in 
1xPBS for 1hr. Then slides were incubated in a wet chamber with first antibody over 
night at 4°C in respective dilutions made in 5% goat serum. Next morning they were 
washed 3 times for 5min in 1xPBS, incubated with secondary antibody in respective 
dilutions made in 5% goat serum for 30min to 1hr and washed another 3 times with 
1xPBS. In case of using biotinylated antibodies sections were additionally incubated 
with Avidin/ Biotin blocking kit before incubation with primary antibody. Slides were 
treated with fluorescent secondary antibodies, protected from sunlight and mounted 
in PBS/glycerol until observation. Slides treated with antibodies linked to HRP were 
observed under a light microscope using DAB Tablets. Enzymatic reaction was 
stopped by ddH2O after 7min and slides were additionally stained with Hemalaun for 
3- 5min. Antibodies were used as described below. Apoptotic cells were assessed 
using the TUNEL method and the In Situ Cell Death Detection Kit. 
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Antibody  / Antigen Source (catalog # or 
equivalent) 
Use, dilution 
F4/80 eBioscience 13-4801 IF-F 1:200 
CD11b eBioscience 13-0112 IF-F 1:200 
Ki67 Neomarkers RM-9106-S1 IF-P 1:200 
Nkx3-1 Santa Cruz sc-15022 IB 1:400 
Smooth muscle actin Sigma C6198 IF-P 1:400 
IF-F 1:400 
Beta-Tubulin Santa Cruz sc-9104 IB 1:400 
A555 goat anti rabbit Invitrogen A-21428 IF-P, IF-F 1:2000 
Biotin anti rabbit Vector Laboratories BA-1000 IHC-P 1:400 
Biotin anti goat Vector Laboratories BA-9500 IHC-P 1:400 
Biotin anti mouse Vector Laboratories BA-9200 IHC-P 1:400 
Streptavidin, Alexa Fluor 
555-conjugate 
Invitrogen S32355 IF-F 1:500 
Abbreviations: IF immunofluorescence, IHC, immunohistochemistry F: frozen 
sections, P: paraffin sections, IB: Immunoblot, 
Table 5: List of antibodies used in this study 
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2.10  Immunoblot analysis 
2.10.1  Protein Isolation from prostate tissue 
Solutions and Buffer 
5x Loading dye: 
0,5ml glycerol 
0,5ml 20% SDS 
0,11ml Tris HCl pH 6.8 
1mg bromophenol blue 
2x dye was produced by dilution from 5x dye, and 2% mercaptoethanol was added 
before use. 
 
For protein isolation from prostate tissue, 800µl of ice-cold acetone was added to 
200µl of flow-through from RNA isolation. This solution was incubated for 10 min at -
20°C and centrifuged for another 10 min for 16000g at 4°C. To the protein pellets 
100µl of 75% ethanol was added and samples were centrifuged for 5 min at full 
speed (4°C). Finally the pellet was dried for 10min at room temperature and 
resuspended in 2x protein loading dye and heated at 95°C to load the suspension on 
the SDS page.  
2.10.2  SDS PAGE 
Solutions and Buffer 
Running Buffer (5x) 
15.1g Tris 
94g Glycin 
&900ml with ddH2O 
50ml 10% SDS 
&1000ml with ddH2O 
Resolving gel/I (10ml/15%) 
4ml ddH2O 
3,3ml 30% acrylamide mix 
2,5 ml 1,5 M Tris pH 8,8 
0,1ml 10% SDS 
0,1ml 10% ammonium persulfate 
0,004ml TEMED 
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Resolving gel/II (10ml/12%) 
4,3ml ddH2O 
3ml 30% acrylamide mix 
2,5ml 1,5 M Tris pH 8,8 
0,1ml 10% SDS 
0,1ml 10% ammonium persulfate 
0,004ml TEMED 
 
Stacking gel (4ml) 
2,7ml ddH2O 
0,67 30% acrylamide mix 
0,5 ml 1 M Tris pH 6,8 
0,04ml 10% SDS 
0,04ml 10% ammonium persulfate 
0,004ml TEMED 
 
10x TBS 
24,4g Tris 
80gNaCl 
 
TBST 
1xTBS 
0,1% Tween 
 
Isolated proteins were loaded on 12% or 15% SDS gels and were dissolved at 180V 
for 1 1/2hr. 
 
2.10.3  Western blotting 
Solutions and Buffer 
Transfer Buffer 
3g Tris 
14,4g Glycin 
 
&800ml with ddH2O 
200ml pure methanol  
 
For blotting we used PVDF membrane (6,2x 7,6cm) and it was performed at room 
temperature at 0,16- 0,2 Ampere for 90min. 
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2.10.4  Ponceau S Staining 
Solutions and Buffer 
Ponceau S solution 
0,5g Ponceau S 
1ml acetic acid 
99ml ddH2O 
 
Membrane was incubated for 3min in Ponceau S Staining solution and afterwards 
washed 3-4 times with ddH2O. 
2.10.5  Antibody treatment 
Solutions and Buffer 
Pierce SuperSignal West Femto (Pierce) 
 
Blots were blocked using either in 5% milk powder diluted 1xTBST or 1% BSA diluted 
in 1xTBST and incubated with primary antibody diluted in blocking solution over 
night. Next morning blots were washed 3 times 5min in 1xTBST, then incubated with 
secondary antibody diluted in equal solution for 30min for 1hr and washed again 3 
times 5min with 1xTBST. For developing the blots we used Pierce SuperSignal West 
Femto. 
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3 Results 
3.1 mRNA expression analysis 
To reveal the molecular biological link between inflammation and cancer Andreas 
Birbach started the project with Microarray analysis to get an overview of up and 
down regulated genes located to the prostate epithelium in PE-PTEN+/-IKK2ca/ca 
vs. PTEN+/- mice and continued with real-time RT-PCR analysis to confirm 
differences in gene expression to explain phenotypic differences of PE-PTEN+/- 
IKK2ca/ca, PE-PTEN+/-, wildtype and additionally IKK2ca/ca mouse prostates 
(Fig.8).  
 
Figure 8: Steromicroscopical images of PE-PTEN+/-IKK2ca/ca, PE-PTEN+/- and wildtype 
litermates showing the structures surounding the urethra (u), bladder (bl) and seminal vesicles 
(SV) from 12months- old mice. Prostate lobes are seen between the noted structures31. !
3.1.1 Chip Analysis 
Microarray experiment revealed that constitutive active IKK2 gene on a monoallelic 
PTEN background (PE-PTEN+/-IKK2ca/ca) leads to a much higher upregulation of 
factors known to be linked to inflammation and cancer development as it was seen in 
PTEN+/- mice (PE-PTEN+/-). We summarized the most upregulated and 
downregulated genes and related them to functional groups to get an idea in which 
direction we should go in further experiments. 
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The gene expression profile of double transgenic mice showed a quite intense 
upregulation of factors associated with immune cell attraction, activation and 
stimulation. Interestingly some factors, known to be linked to invasiveness, such as 
smooth muscle cell markers, serine protease inhibitors and some prostate specific 
genes are downregulated. All together this experiment gave us a starting point of the 
transgenic mouse models we wanted to use in our prostate cancer project. 
3.1.2 Real-time RT-PCR 
Using real-time RT PCR we wanted to know if the Flag- tagged KK2 gene 
expression, following excision of the Stop cassette in Rosa26-FIStop-IKK2ca/ca 
mice, is expressed in prostate tissue. Furthermore we wanted to konow if there is a 
difference in the expression level of the transgene in lateral (LP), anterior (AP), dorsal 
(DP) and ventral prostate lobes (VP).  
Further we performed expression analysis on PE-PTEN+/- IKK2ca/ca, PE-PTEN+/-, 
PE-IKK2ca/ca and wildtype lateral prostates to compare again the influence of the 
different genotypes on the expression level of transgenic mice, to get an idea of 
molecular link between inflammation and cancer. 
3.1.2.1 Expression level of the constitutive active IKK2 gene 
On mRNA level it was shown by Andreas Birbach that the transgene is expressed in 
the different lobes and that the transgene expession was highest in the lateral 
prostate (LP), followed by the anterior (AP) and dorsal prostate (DP) with lowest 
expression level in the ventral prostate (VP)  
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3.1.2.2 Upregulated genes in transgenic prostate tissue 
3.1.2.2.1 Chemokines 
Consistent with Chip Analysis the mRNA level of the chemokines CXCL5, CXCL2, 
CXCL15 and CXCL10 was increased in PE-PTEN+/- IKK2ca/ca lateral prostates in 
contrast to PTEN+/-, IKK2ca/ca and wildtype (Fig.9-12). These genes are known to 
be upregulated in inflammatory processes, attracting immune cells to the affected 
tissue. Particularly neutrophil granulocytes and monocytes/macrophages interact with 
these molecules to reach the inflamed tissue. 
 
Figure 9: mRNA expression level of inflammatory cytokine CXCL5 in lateral prostate tissue of 
transgenic mice and wildtype mice. 
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Figure 10: mRNA expression level of inflammatory cytokine CXCL15 in lateral prostate tissue 
of transgenic mice and wildtype mice. 
 
 
 
Figure 11: mRNA expression level of inflammatory cytokine CXCL10 in lateral prostate tissue 
of transgenic mice and wildtype mice. 
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Figure 12: mRNA expression level of inflammatory cytokine CXCL2 in lateral prostate tissue of 
transgenic mice and wildtype mice. 
 
3.1.2.2.2  Cytokines and NFkB target genes 
Another group of overexpressed genes in PE-PTEN+/-IKK2ca/ca mice are cytokines, 
particularly TNF! (Fig.13) an NFkB target molecule indicating an inflammatory 
process going on in the prostate tissue. Another overexpressed molecule among 
NFkB target genes is the intercellular adesion molecule ICAM1 (Fig.14).  
 
 
Figure 13: mRNA expression level of inflammatory chemokine TNF!  in lateral prostate tissue 
of transgenic mice and wildtype mice. 
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Figure 14 mRNA expression level of intercellular adhesion molecule ICAM I in lateral prostate 
tissue of transgenic and wildtype mice. 
 
3.1.2.2.3  Secreted frizzled-related proteins 
Additionally we could confirm the upregulation of the secreted frizzle related proteins 
1 and 4 (SFRP1 and SFRP4) (Fig.15, 16) in PE-PTEN+/-IKK2ca/ca mice. SFRP1 has 
been described as a candidate gene expressed by the stroma to modulate the 
epithelium in prostate cancer progression26, showing that the activated stroma in our 
intraepithelial tumors bears resemblance to human prostate cancer stroma.  
 
Figure 15 mRNA expression level of SFRP I in lateral prostate tissue of transgenic and 
wildtype mice 
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Figure 16: mRNA expression level of SFRP IV in lateral prostate tissue of transgenic and 
wildtype mice 
 
3.1.2.2.4  Others 
Another upregulated gene is the trypsin-like serine protease Hepsin known to be 
overexpressed in many human prostate cancers 33(Fig.17) 
In addition the neutrophil marker Lipocalin2 could be verified as an upregulated gene 
in the transgenic prostate tissue (Fig.18). 
 
Figure 17: mRNA expression level of trypsin-like serine protease Hepsin in lateral prostate 
tissue of transgenic and wildtype mice 
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Figure 18: mRNA expression level of trypsin-like serine protease Lipocalin2 in lateral prostate 
tissue of transgenic and wildtype mice !
! $%!
3.1.2.3 Downregulated genes in transgenic prostate tissue 
3.1.2.3.1  Genes linked to Invasiveness 
3.1.2.3.1.1 Smooth muscle cell markers 
In line with the results from Chip Analysis the most downregulated genes are smooth 
cell markers Myosin Heavy Chain 11 (MYH11) (Fig.19) and Smooth Muscle Actin 
(SMA) (Fig.20), loss of these proteins have been used as indicators for invasive 
carcinoma formation15,34. Furthermore microarray data revealed that Calponin 1 is 
downregulated, a protein that is known to regulate the actin/myosin interaction in 
smooth-muscle cells35. 
 
Figure 19: mRNA expression level of smooth muscle cell marker MYH11 in lateral prostate 
tissue of transgenic and wildtype mice 
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Figure 20: mRNA expression level of smooth muscle cell marker SMA in lateral prostate tissue 
of transgenic and wildtype mice 
 
3.1.2.3.1.2 Serin protease inhibitors 
Chip analysis showed that a group of serin protease inhibitors is downregulated in 
PE-PTEN+/-IKK2ca/ca mice, most of all Serine Protease Inhibitor 3 (Spink3). Via 
real-time RT-PCR we could confirm this result (Fig.21). Spink3 is documented to be a 
biomarker upregulated in a subset of aggressive ETS (E-twenty six) negative 
prostate cancers23 and could be an indication for a lack of invasiveness in our mouse 
model.  
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Figure 21: mRNA expression level of Serin Protease Inhibitor Spink3 in lateral prostate tissue 
of transgenic and wildtype mice !
3.1.2.3.1.3  Prostate specific genes 
Verifying Chip Analysis we could show that the transcription factor NK3 (Nkx3.1) is 
downregulated in PE-PTEN+/-IKK2ca/ca mice (Fig.22). Nkx3.1 is a protein frequently 
lost in human prostate cancer and its loss in mouse models leads to hyperplasia and 
dysplasia that worsens with age20,36,37  
 
Figure 22: mRNA expression level of the transcription factor Nkx3.1 in lateral prostate tissue 
of transgenic and wildtype mice !
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3.1.2.4  Variation in Genexpression of transgenic Epithelial and Stromal cells 
For this experiments stromal and epithelial cells of PE-PTEN+/-IKK2ca/ca transgenic 
mice and wildtype littermates were established by Andreas Birbach by explant 
cultures (Fig.23). These cell lines were used to check whether the Flag-IKK2 
transgene is expressed in the transgenic epithelium and if the inflammatory cytokines 
and chemokines are expressed in the whole prostate tissue, or produced by the 
transgenic epithelium only. Moreover we wanted to compare gene expression profiles 
of the different cell lines and additionally we wanted to know if and in which way the 
transgenic epithelium influences the stromal cell gene expression. 
 
Figure 23: Explant cultures of epithelial and stromal cells from PE-PTEN+/-IKK2ca/ca and wild 
type prostate tissues31. 
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3.1.2.4.1  Expression of the constitutively active IKK2 gene 
In epithelial lines from PE-PTEN+/-IKK2ca/ca mice the Flag-IKK2 transgene is only 
expressed in this cell line (Fig.24). 
 
Figure 24: mRNA expression level of the Flag-tag of IKK2 in lateral prostate cells of PE-
PTEN+/-IKK2ca/ca mice. 
 
3.1.2.4.2  Upregulated genes in transgenic epithelial cells in contrast to wild 
type epithelial cells compared to genexpression of transgenic stromal 
cells 
In this part of the experiment we wanted to confirm that transgenic epithelial cells 
from PE-PTEN+/-IKK2ca/ca mice prostates show an upregulation of factors involved 
in inflammation and prostate cancer progression in contrast to non-transgenic 
epithelial cells (wildtype epithelial cells). Furthermore we wanted to compare the 
gene expression profile of transgenic epithelial cells to transgenic stromal cells both 
isolated from PE-PTEN+/-IKK2ca/ca mice prostates. 
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3.1.2.4.2.1 Chemokines 
We could show that the chemokines CXCL5 and CXCL15 were significant and 
CXCL10 and CXCL2 moderate upregulated in transgenic epithelial cells in contrast to 
non-transgenic epithelial cells. Furthermore we could show that chemokine 
overexpression is only located to the transgenic epithelium and not to the stroma 
(Fig.25-28). 
 
Figure 25: Comparison of mRNA expression level of inflammatory chemokine CXCL5 in 
transgenic epithelial cells isolated from PE-PTEN+/-IKK2ca/ca lateral prostates to non- 
transgenic (wildtype) epithelial cells and contrast of mRNA expression level of CXCL5 in 
transgenic-epithelial and –stromal cells both isolated from PE-PTEN+/-IKK2ca/ca lateral 
prostates. 
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Figure 26: Comparison of mRNA expression level of inflammatory chemokine CXCL15 in 
transgenic epithelial cells isolated from PE-PTEN+/-IKK2ca/ca lateral prostates to non- 
transgenic (wildtype) epithelial cells and contrast of mRNA expression level of CXCL15 in 
transgenic-epithelial and –stromal cells both isolated from PE-PTEN+/-IKK2ca/ca lateral 
prostates. 
 
 
 
Figure 27: Comparison of mRNA expression level of inflammatory chemokine CXCL10 in 
transgenic epithelial cells isolated from PE-PTEN+/-IKK2ca/ca lateral prostates to non- 
transgenic (wildtype) epithelial cells and contrast of mRNA expression level of CXCL10 in 
transgenic-epithelial and –stromal cells both isolated from PE-PTEN+/-IKK2ca/ca lateral 
prostates. 
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Figure 28: Comparison of mRNA expression level of inflammatory chemokine CXCL2 in 
transgenic epithelial cells isolated from PE-PTEN+/-IKK2ca/ca lateral prostates to non- 
transgenic (wildtype) epithelial cells and contrast of mRNA expression level of CXCL2 in 
transgenic-epithelial and –stromal cells both isolated from PE-PTEN+/-IKK2ca/ca lateral 
prostates. 
 
 
3.1.2.4.2.2 Cytokines and NFkB target genes 
Moreover we could show that the inflammatory cytokine and NFkB target gene TNF! 
is upregulated in transgenic epithelial cells in contrast to wildtype cells (Fig.29) and 
that its expression is only increased in transgenic epithelial cells not in transgenic 
stromal cells. Additionally it was confirmed by David Eisenbarth that the cell adhesion 
molecule ICAM1 is upregulated in transgenic epithelial cells in contrast to epithelial 
wildtype cells and that itʼs overexpression is located to the transgenic epithelium too. 
ICAM1 is a protein described as a neutrophil granulocyte receptor32 and therefore 
involved in immunological responses. 
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Figure 29: Comparison of mRNA expression level of TNF!  in transgenic epithelial cells 
isolated from PE-PTEN+/-IKK2ca/ca lateral prostates to non- transgenic (wildtype) epithelial 
cells and contrast of mRNA expression level of TNF!  in transgenic-epithelial and –stromal 
cells both isolated from PE-PTEN+/-IKK2ca/ca lateral prostates. 
 
3.1.2.4.2.3 Others 
Futhermore the type-1 transmembrane cell-cell adhesion glycoproteinprotein  
E-cadherin, shown by David Eisenbarth and the luminal cell marker Cytokeratin18 
(Fig.30) were upregulated. In one wildtype and one transgenic epithelial line (epII) we 
could verify an overexpression of the cytoskeletal Cytoceratin 14 gene while in 
another transgenic line (epI) not. Suggesting that eplI has a more intermediate 
character while epl shows a more luminal phenotype. As well we could detect an 
upregulation of the neutrophil marker Lipocalin2 (Fig.31) documented as upregulated 
in several epithelial cancers such as prostate cancer38. 
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Figure 30: Comparison of mRNA expression level of Cytoceratin18 in transgenic epithelial 
cells isolated from PE-PTEN+/-IKK2ca/ca lateral prostates to non-transgenic (wildtype) 
epithelial cells and contrast of mRNA expression level of Cytoceratin18 in transgenic-epithelial 
and –stromal cells both isolated from PE-PTEN+/-IKK2ca/ca lateral prostates. 
 
 
 
Figure 31: Comparison of mRNA expression level of Lipocalin2 in transgenic epithelial cells 
isolated from PE-PTEN+/-IKK2ca/ca lateral prostates to non- transgenic (wildtype) epithelial 
cells and contrast of mRNA expression level of Lipocalin2 in transgenic-epithelial and  
–stromal cells both isolated from PE-PTEN+/-IKK2ca/ca lateral prostates. 
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3.1.2.4.3  Upregulated genes in transgenic stromal cells in contrast to wild type 
epithelial cells compared to genexpression of transgenic epithelial 
cells 
3.1.2.4.3.1 Frizzle related proteins 
Still we could show that the frizzle related proteins SFRP1 and SFRP4 are 
upregulated (Fig.32, 33). SFRP1 has been documented to be involved to the 
modulation of the epithelium in prostate cancer progression.26 
 
Figure 32: Comparison of mRNA expression level of SFRPI in transgenic epithelial cells 
isolated from PE-PTEN+/-IKK2ca/ca lateral prostates to non- transgenic (wildtype) epithelial 
cells and contrast of mRNA expression level of SFRPI in transgenic- epithelial and –stromal 
cells both isolated from PE-PTEN+/-IKK2ca/ca lateral prostates. 
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Figure 33: Comparison of mRNA expression level of SFRP IV in transgenic epithelial cells 
isolated from PE-PTEN+/-IKK2ca/ca lateral prostates to non- transgenic (wildtype) epithelial 
cells and contrast of mRNA expression level of SFRP IV in transgenic- epithelial and –stromal 
cells both isolated from PE-PTEN+/-IKK2ca/ca lateral prostates. 
 
 
3.1.2.4.4  Stromal transgenic cultures stimulated with TNF! 
It was shown by David Eisenbarth that the stroma of transgenic mice prostates could 
be activated from cytokines produced by the transgenic epithelium and hence is able 
to express immune cell attracting chemokines. Stromal cell line of PE-PTEN+/-
IKK2ca/ca mouse prostate was stimulated with TNF! and the chemokine level was 
checked after 24 and 48h. Certainly CXCL2 and to a minor extent CXCL10, but 
surprisingly not CXCL5 or CXCL15, were overexpressed after TNF! treatment. 
! %'!
3.1.2.4.5  Epithelial transgenic cell line stimulated with IKK2/ NFkB inhibitor 
BMS-345541 
In this experiment we wanted to prove that the transgenic activation of the IKK2/ 
NFkB axsis is responsible for overexpression of cytokines and chemokines in the 
prostate tissue. In the transgenic (PTEN+/- IKK2ca/ca) epithelial cell line epI the 
TNF! gene is significantly downregulated after BMS treatment (Fig.34) and we could 
show a downregulation of CXCL5 (Fig.35), one of the most upregulated chemokines 
in double transgenic prostate tissue.  
 
Figure 34: mRNA expression level of inflammatory cytokine TNF!  in epithelial cell line treated 
with mock control or BMS-345541 for 72 hours. 
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Figure 35: mRNA expression level of inflammatory chemokine CXCL5 in epithelial cell line 
treated with mock control or BMS-345541 for 72 hours. 
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3.2 Protein level verification in transgenic prostate tissue and cell 
lines 
3.2.1 Immunoblot analysis 
We did Immunoblot analysis to confirm the upregulation or downregulation of genes 
identified by Chip Analysis or real-time RT-PCR on protein level. 
3.2.1.1 Verification of protein level in transgenic prostate tissues 
3.2.1.1.1  Nkx3.1 
This blot shows the lower protein amount of Nkx3.1 in PE-PTEN+/- IKK2ca/ca mouse 
prostates in contrast to wild type mice. By analysing data of the housekeeping gene 
"-Tubulin it was shown that although there is most amount of protein loaded in PE-
PTEN+/-IKK2ca/ca mice slots, the concentration of Nkx3.1 is lower in contrast to 
wildtype littermates. Interestingly the amount of housekeeping gene Actin is highest 
in wildtype prostates, exactly the other way around as it was revealed with "-Tubulin 
on the same blot (Fig.36). This result confirms the downregulation of Smooth Muscle 
Actin (SMA) detected in Chip Analysis and real-time RT PCR analysis and Tissue 
staining. 
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Figure 36: Immunoblot analysis from protein isolates of transgenic prostate tissue and 
wildtype targeting Nkx3.1. 
 
3.2.1.2 Verification of protein level in explant cell cultures of transgenic 
prostate tissues 
3.2.1.2.1  IkB! 
Via Immunoblot we could show that IkB level is highest in wildtype and in PE-PTEN-/- 
mice and decreased in PE-PTEN+/-IKK2ca/ca mice. This should be due to 
phosphorylation by IKK2 kinase and subsequent ubiquitinylation and degradation of 
IkB in case of an inflammatory stimulation in double transgenic mice. This finding is 
consistent with other results in this project and stands for an intense activation of the 
NFkB pathway based on constitutive active IKK2 kinase. Unfortunately it was not 
possible to detect the phosporylated version of IkB (pIkB), we speculate that the turn 
over rate of pIkB is quite fast so that we were not able to detect this protein (Fig. 37).  
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Figure 37: Immunoblot Analysis from transgenic explant cell cultures of transgenic prostate 
tissue showing protein level of IkB! . "-Tubulin was used as housekeepinggene. 
 
In the second blot targeting the same protein we wanted to verify differences in NFkB 
pathway activation through degradation of IkB! in the different prostate lobes 
(Fig.38). Unfortunately the second immuno blot concerning IkB! was not that 
meaningful as we expected. In Fact the IkB! concentration is slightly decreased in 
PE-PTEN+/-IKK2ca/ca mice in comparison to wildtype but the protein level should be 
much more decreased in transgenic mice through the constitutive IKK2 kinase. 
 
 
Figure 38: Immunoblot analysis from transgenic explant cell cultures of transgenic prostate 
tissue showing protein level of IkB!  in AP; DP and LP of PE-PTEN IKK2ca/ca in comparison to 
wildtype prostate cells. "-Tubulin was used as housekeeping gene. 
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3.2.1.2.2   pIkB! 
In PE-PTEN+/-IKK2ca/ca mice IkB! should be present in its phosphorylated form to 
be ubiquitinylated and degraded permitting NFkB transcription factor to be 
translocated to the nucleus. Unfortunately it was not possible to demonstrate that the 
phosphorylated version of IkB! (pIkB!) is present in PE-PTEN+/-IKK2ca/ca mice, we 
speculate that the turnover rate of pIkB! makes it quite difficult to detect it. 
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3.3 In situ analysis of transgenic prostate tissue 
Previously main parts of experiments insitu were performed by Andreas Birbach 
assisted by Diplomastudent David Eisenbarth and parts of them were repeated by 
myself. Pictures that are not shown in my thesis can be found in the paper 
“Persistent inflammation leads to proliferative neoplasia and loss of smooth muscle 
cells in a prostate tumor model31. 
3.3.1 Tissue staining 
With tissue staining we wanted to show in situ that the Flag-tagged IKK2 transgene is 
definitely expressed in the epithelium. Furthermore we wanted to show that there is 
an increase in tumor size and epithelial and stromal proliferation in PE-PTEN+/-
IKK2ca/ca in comparison to PTEN+/-, PE-IKK2ca/ca and wildtype mice. 
Additionally we wanted to confirm that there is an inflammatory process going on as 
well as an immune cell infiltration to the affected tissue. Moreover we tried to field the 
question whether there are invasive cells and factors that could probably be involved 
in this process.  
3.3.1.1 In situ detection of constitutive active IKK2 gene 
It was shown by Andreas Birbach that the Flag-tag of the IKK2 protein is expressed 
and restricted to the transgenic epithelium using an antibody specific for Flag 
(Fig.39). Question was now if the constitutive active IKK2 gene in epithelial cells of 
the prostate is able to transform prostate tissue. 
Therefore histological assessment of prostate lobes from the diverse transgenic 
prostate tissues at different time points was performed but there were no histological 
relevant changes in mice expressing the constitutive active IKK2 gene after 4(n=3), 
8(n=4) or 12(n=10) months of age, neither in animals expressing IKK2 (IKK2ca) from 
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a single allele nor in animals expressing the transgene from both alleles (IKK2ca/ca). 
Hence it was concluded that a constitutive active IKK2 and therein permanent active 
NFkB pathway is not able to transform prostate tissue. 
 
Figure 39: Anti Flag stain in PE-IKK2ca/ca and wildtype mice31. 
 
3.3.1.2  Prostate-specific monoallelic loss of PTEN combined with IKK2ca/ca 
expression 
It was shown that permanent active NFkB/IKK2 axsis on a PTEN+/- background 
leads to a visible increase in prostate size after 12 months and significant 
alternations after 8 months. After 4 months no alternations have been noticed in 
prostate tissue. Mice expressing the IKK2 transgene on both alleles (PE-PTEN+/- 
IKK2ca/ca) showed enlarged tissue in all lobes after 8 months. Older mice 
expressing the transgene on one allele (PE-PTEN+/- IKK2ca) only showed enlarged 
lateral prostates where the transgene expression was shown to be highest. 
3.3.1.3  Prostate size and changes in the transgenic tissue  
Performing immunohistochemistry it was illustrated that PE-PTEN+/- IKK2ca/ca 
mouse prostates show severe hyperplasic changes which often led to cribriforum 
structures. They had equal incidence of nuclear atypia as PE-PTEN+/- mice 
epithelium. PE-PTEN +/- mouse prostates showed hyperplasia and focal nuclear 
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abnormalities also referred as prostatic intraepithelial neoplasia (PIN). Wildtype 
mouse prostates showed normal, smooth epithelium lacking any hyperplasic or 
noticeable abnormalities. In addition PE-PTEN+/- IKK2ca/ca mouse prostates 
showed a clear indication for stromal changes with numerous collagen fibers in 
comparison to the loose stroma with a few fibers in PE-PTEN+/-, PE-IKK2ca/ca and 
wildtype. 
3.3.1.4  Cell proliferation and apoptosis in transgenic tissue 
Coincident with mentioned changes in prostate tissue we could show an increased 
level of proliferation marker32 Ki67 positive epithelial and stromal cells (Fig.41). 
TUNEL-staining, which is a method to show apoptotic cell processes, was low and 
not significantly changed in one of the genotypes, revealing indeed an increase of 
cell proliferation in PE-PTEN+/-IKK2ca/ca mice but not in apoptosis (Fig. not shown). 
 
Figure 40: paraffin sections of lateral prostates (12months) stained for proliferation marker 
Ki67. Positive epithelial cells (arrowhead) and stromal cells (arrow) were seen31. !
3.3.1.5 Inflammatory processes in transgenic tissue 
It was shown that PE-PTEN+/- IKK2ca /ca mice had an increased tendency of severe 
prostatitis in disparity to young PE-PTEN+/- (4months:n=3, 8months: n=5) and 
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IKK2ca/ca mice where no signs of prostatitis occurred. Anyway a number of PE- 
PTEN+/- mice developed signs of severe prostatitis with around 12 months (Fig. not 
shown). 
3.3.1.6  Infiltration of immune cells to the transgenic tissue 
As we expected the transgenic tissue, especially PE-PTEN+/-IKK2ca/ca mice 
showed an increased rate of immune cell infiltration. This was shown by staining for 
the neutrophil marker Lipocalin2 and it was seen that neutrophil granulocytes infiltrate 
the stroma and the epithelium where they could be well spotted in lumina of 
cribriforum structures. 
In Immunoflourescence analysis we could moreover demonstrate an infiltration of 
macrophages/monocytes, neutrophils and to a lesser extent leukocytes in PE-
PTEN+/-IKK2ca/ca mice in contrast to control tissues. For this purpose we used the 
macrophages/monocytes antigen CD11b, the macrophage marker F4/80 and the 
neutrophil marker Gr-1 (Fig.43).  
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Figure 41: Antibodystaining of cryosecions from dorsal prostates of PE-PTEN+/-IKK2ca/ca 
mice using CD11b, F4/80 and Gr-1 antibodies31. 
3.3.1.7  Androgen receptor (AR) 
Tissue staining with an antibody against the prostate specific transcription factor AR 
revealed a lower nuclear activated level of androgen receptor in PE-PTEN+/- IKK2ca 
/ca mice in contrast to wildtype prostate epithelial cells (Fig.44). Decrease of AR 
activity was already indicated in Chip Analysis by a downregulation of other 
androgen-responsive genes such as Probasin. Furthermore AR is known being 
linked to the expression of prostate specific transcription factor Nkx3.1 that is well 
established to be decisive for cell proliferation in prostate20. 
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Figure 42: Paraffin sections of lateral prostates (12months) stained for Androgen Receptor 
(AR). Same tissues were stained for Hoechst to indicate tissue structure31. 
 
3.3.1.8  Factors involved in Invasiveness 
So far dramatic changes in stroma of the transgenic prostate tissue were investigated 
by histological staining and revealed by real-time RT-PCR presuming a phenotype 
that might show signs of invasivenes. 
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3.3.1.8.1  Smooth muscle cell markers 
Results concerning the downregulation of smooth cell markers, smooth muscle 
myosin heavy chain (MYH11) and Smooth Muscle Actin (SMA) in PE-PTEN+/-
IKK2ca /ca prostates compared to PE-PTEN+/-, PE-IKK2ca/ca and wildtype were 
confirmed by staining lateral prostates with SMA antibody. Staining revealed that in 
PE-PTEN+/-IKK2ca/ca prostates, Smooth Muscle Cells around many prostatic ducts 
were lost. 
3.3.1.8.2  Basal cell marker 
The loss of basal cells in the epithelium is an indication for invasive tumor formation. 
By Co-staining of smooth muscle marker and the basal cell marker p63 it was shown 
that although there was even in the glands with a complete smooth muscle cell loss a 
preserved basal cell expression. The larger tumors in PE-PTEN+/-IKK2ca/ca 
prostates showed no signs of “dripping off” of smaller epithelial structures or even 
invasion to neighbouring tissue. 
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4 Discussion 
In this study we wanted to define a gene expression profile that differs in prostate 
cancer tissue in contrast to normal tissue with special focus on a permanent 
inflammatory stimulation and the link to cancer progression. For this reason we used 
a mouse model that is able to express a constitutive active form of the key mediator 
of the inflammatory NFkB pathway IKK2, using the well-described Cre/LoxP system. 
Further we wanted to reveal what phenotype results out of an additional PTEN 
deficiency. PTEN is a gene that is documented to be mutated in prostate 
carcinogenesis in a frequent manner13-15. Using these tools we wanted to get an idea 
of how prostate cancer development and inflammation could be linked and which 
factors could be involved therein. 
Interestingly no histological relevant changes in mice expressing the constitutive 
active IKK2 gene were seen. Beside we could not reveal significant changes in gene 
expression profile. For this reason we conclude that a constitutive active IKK2 and 
therein permanent active NFkB pathway is not able to transform prostate tissue in 
this mouse model. This is curious because IKK2 has been documented as an 
oncogenic kinase and results in double transgenic mice in an obvious phenotype with 
increased inflammation and activated stroma, hyperplasia as well as appropriate 
changes in gene expression, being constitutive active on a PE- PTEN+/- background.  
Beside the fact that IKK2 is known as an onkogenic kinase, it was recognized that 
long time treatment of Aspirin, an inhibitor of IKK2, decreases prostate cancer risk 
arguing for an important role therein. 
Furthermore we speculate that the reason for a lacking inflammatory phenotype in 
PE-IKK2ca/ca mice could be that NFkB transcription factor is activating promotors in 
! '+!
proliferating epithelium that cannot be activated in quiescent epithelium such as the 
prostate epithelium. Reason for that speculation is that Andreas Birbach bread mice 
that express the same constitutive version of IKK2 on same genetic background but 
in keratinocytes of the skin a proliferating epithelium resulting a clear phenotype 
(Birbach et al. unbublished). Furthermore Probasin Cre mice excise flanked gene 
sides only in adult mice harbouring a already quiescent prostate epithelium. This is 
consistent with the finding that PE-PTEN+/-IKK2 develop a phenotype described 
above. 
Double transgenic mouse prostates are characterized by an infiltration of neutrophil 
granulocytes and macrophages/monocytes indicated by staining with antibodies 
against Gr-1, CD11b and F4/80. This immune cell infiltration is founded in NFkB-
dependent overexpression of cytokines, primarily IL1b and TNF!, responsible for 
stimulation of immune cells and production of chemokines such as CXCL5, CXCL15, 
CXCL3, CXCL10 and CXCL2 responsible for immune cell attraction assumingly via 
binding of chemokine receptors and selectines. Stimulation of transgenic stromal 
cells with TNF! indicated that immune cells could be attracted directly via transgenic 
epithelial cells and their produced chemokines or indirect by cytokines produced by 
the epithelum activating chemokine production in the stroma cells.  
Immune cell infiltration is much lower in PE-PTEN+/- mice and in wildtype in contrast 
to PE-PTEN+/-IKK2ca/ca, a finding that is coherent with expression profile and 
histological data of these mouse models. These data show that inflammation 
processes going on in transgenic prostate tissue is the basic source of the phenotype 
of transgenic mice we worked with.  
Moreover the adhesions molecule ICAM1, that is known to be produced by 
stimulation of cytokines and responsible for immune cell attraction too. 
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Double transgenic mice did not show any signs of invasive tumor formation although 
many factors that are known to be involved in prostate cancer progression are 
deregulated, such as secreted frizzled related proteins SFRPI and SFRPIV. These 
genes, expressed by stromal cells, could contribute to abnormal proliferation in 
prostate epithelium and could support prostate cancer progression26. Another 
frequent mutated gene in Prostate cancer is hepsin, a serine protease that is 
documented to promote primary prostate cancer progression and metastasis28  
Furthermore smooth muscle actin (SMA), myosin heavy chain 11 (MYH11) and 
Calponin 1 were significantly downregulated indicating a loss of smooth muscle cells 
frequently lost in prostate cancer. This result was confirmed by histologic staining 
showing loss of smooth muscle around stratified epithelium. 
We speculate that probably the remaining basal cell layer indicated by p63 staining 
could be a reason why tumors are not invasive although smooth muscle cells were 
lost. 
Furthermore the androgen receptor target gene Nkx3.1, only downregulated in 
double transgenic mice, but known to be frequently lost in prostate cancer could be a 
potential reason for lacking of invasiveness in PE-PTEN+/-IKK2 ca/ca mice. Nkx3.1 
downregulation moreover correlates with reduced activity of AR that could be 
influenced by modified stromal-to-epithelial signalling that is perhaps influenced 
among others via SFRP1.  
Additionally Spink3 is downregulated in double transgenic mice and is assumed to be 
involved to invasiveness of prostate tumors if it is overexpressed. Downregulation of 
this serine protease inhibitor could also account for a lack of invasive character in 
double transgenic mice.  
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In total our results give an impression of how inflammation could be linked to prostate 
cancer formation although the final transforming step in mice models we used in this 
project was not detected. We think that tumors could become invasive in case of a 
longterm study under same condition postulating additional genomic mutations 
caused by events subsequent to inflammatory stimulation.  
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5.2 Figures 
Figure 1: Comparison of a mouse and human prostate. Taken from: Ahmad, I., 
Sansom, O.J. & Leung, H.Y. Advances in mouse models of prostate cancer. Expert 
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Figure 2: Cellular and molecular model of early prostate neoplasia progression. 
Taken from: De Marzo, A.M., et al. Inflammation in prostate carcinogenesis. Nat Rev 
Cancer 7, 256-269 ########################################################################################################################################### '!
Figure 3: An illustration of the inflammatory NFkB pathway. Taken from: Schmid, J.A. 
& Birbach, A. IkappaB kinase beta (IKKbeta/IKK2/IKBKB)--a key molecule in 
signaling to the transcription factor NF-kappaB. Cytokine Growth Factor Rev 19, 157-
165############################################################################################################################################################################ )!
Figure 4: CRE recombinase gene under the control of the ARR2PB promotor 
expressed in Probasin-Cre mice. ###########################################################################################################"$!
Figure 5: Transgenic gene cassette for CRE-mediated deletion of PTEN #######################"$!
Figure 6: Transgenic gene cassette for CRE-mediated expression of IKK2 gene#######"%!
Figure 7: Genetic background of IKK2ca/ca, PE-PTEN+/-(-/-) and PE-PTEN+/-
IKK2ca/ca mice ################################################################################################################################################"%!
Figure 8: Steromicroscopical images of PE-PTEN+/-IKK2ca/ca, PE-PTEN+/- and 
wildtype litermates showing the structures surounding the urethra (u), bladder (bl) 
and seminal vesicles (SV) from 12months- old mice. Prostate lobes are seen 
between the noted structures31. ##############################################################################################################,'!
Figure 9: mRNA expression level of inflammatory cytokine CXCL5 in lateral prostate 
tissue of transgenic mice and wildtype mice. ###################################################################################,)!
Figure 10: mRNA expression level of inflammatory cytokine CXCL15 in lateral 
prostate tissue of transgenic mice and wildtype mice. ################################################################,*!
Figure 11: mRNA expression level of inflammatory cytokine CXCL10 in lateral 
prostate tissue of transgenic mice and wildtype mice. ################################################################,*!
Figure 12: mRNA expression level of inflammatory cytokine CXCL2 in lateral prostate 
tissue of transgenic mice and wildtype mice. ###################################################################################$+!
Figure 13: mRNA expression level of inflammatory chemokine TNF! in lateral 
prostate tissue of transgenic mice and wildtype mice. ################################################################$+!
Figure 14 mRNA expression level of intercellular adhesion molecule ICAM I in lateral 
prostate tissue of transgenic and wildtype mice. ###########################################################################$"!
Figure 15 mRNA expression level of SFRP I in lateral prostate tissue of transgenic 
and wildtype mice ###########################################################################################################################################$"!
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Figure 16: mRNA expression level of SFRP IV in lateral prostate tissue of transgenic 
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Figure 17: mRNA expression level of trypsin-like serine protease Hepsin in lateral 
prostate tissue of transgenic and wildtype mice #############################################################################$,!
Figure 18: mRNA expression level of trypsin-like serine protease Lipocalin2 in lateral 
prostate tissue of transgenic and wildtype mice #############################################################################$$!
Figure 19: mRNA expression level of smooth muscle cell marker MYH11 in lateral 
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Figure 20: mRNA expression level of smooth muscle cell marker SMA in lateral 
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Figure 21: mRNA expression level of Serin Protease Inhibitor Spink3 in lateral 
prostate tissue of transgenic and wildtype mice #############################################################################$'!
Figure 22: mRNA expression level of the transcription factor Nkx3.1 in lateral prostate 
tissue of transgenic and wildtype mice################################################################################################$'!
Figure 23: Explant cultures of epithelial and stromal cells from PE-PTEN+/-IKK2ca/ca 
and wild type prostate tissues31. #############################################################################################################$(!
Figure 24: mRNA expression level of the Flag-tag of IKK2 in lateral prostate cells of 
PE-PTEN+/-IKK2ca/ca mice.####################################################################################################################$)!
Figure 25: Comparison of mRNA expression level of inflammatory chemokine CXCL5 
in transgenic epithelial cells isolated from PE-PTEN+/-IKK2ca/ca lateral prostates to 
non- transgenic (wildtype) epithelial cells and contrast of mRNA expression level of 
CXCL5 in transgenic-epithelial and –stromal cells both isolated from PE-PTEN+/-
IKK2ca/ca lateral prostates. ######################################################################################################################$*!
Figure 26: Comparison of mRNA expression level of inflammatory chemokine 
CXCL15 in transgenic epithelial cells isolated from PE-PTEN+/-IKK2ca/ca lateral 
prostates to non- transgenic (wildtype) epithelial cells and contrast of mRNA 
expression level of CXCL15 in transgenic-epithelial and –stromal cells both isolated 
from PE-PTEN+/-IKK2ca/ca lateral prostates. ################################################################################%+!
Figure 27: Comparison of mRNA expression level of inflammatory chemokine 
CXCL10 in transgenic epithelial cells isolated from PE-PTEN+/-IKK2ca/ca lateral 
prostates to non- transgenic (wildtype) epithelial cells and contrast of mRNA 
expression level of CXCL10 in transgenic-epithelial and –stromal cells both isolated 
from PE-PTEN+/-IKK2ca/ca lateral prostates. ################################################################################%+!
Figure 28: Comparison of mRNA expression level of inflammatory chemokine CXCL2 
in transgenic epithelial cells isolated from PE-PTEN+/-IKK2ca/ca lateral prostates to 
non- transgenic (wildtype) epithelial cells and contrast of mRNA expression level of 
CXCL2 in transgenic-epithelial and –stromal cells both isolated from PE-PTEN+/-
IKK2ca/ca lateral prostates. ######################################################################################################################%"!
Figure 29: Comparison of mRNA expression level of TNF! in transgenic epithelial 
cells isolated from PE-PTEN+/-IKK2ca/ca lateral prostates to non- transgenic 
(wildtype) epithelial cells and contrast of mRNA expression level of TNF! in 
transgenic-epithelial and –stromal cells both isolated from PE-PTEN+/-IKK2ca/ca 
lateral prostates. ##############################################################################################################################################%,!
Figure 30: Comparison of mRNA expression level of Cytoceratin18 in transgenic 
epithelial cells isolated from PE-PTEN+/-IKK2ca/ca lateral prostates to non-
transgenic (wildtype) epithelial cells and contrast of mRNA expression level of 
Cytoceratin18 in transgenic-epithelial and –stromal cells both isolated from PE-
PTEN+/-IKK2ca/ca lateral prostates. ###################################################################################################%$!
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Figure 31: Comparison of mRNA expression level of Lipocalin2 in transgenic 
epithelial cells isolated from PE-PTEN+/-IKK2ca/ca lateral prostates to non- 
transgenic (wildtype) epithelial cells and contrast of mRNA expression level of 
Lipocalin2 in transgenic-epithelial and  –stromal cells both isolated from PE-PTEN+/-
IKK2ca/ca lateral prostates. ######################################################################################################################%$!
Figure 32: Comparison of mRNA expression level of SFRPI in transgenic epithelial 
cells isolated from PE-PTEN+/-IKK2ca/ca lateral prostates to non- transgenic 
(wildtype) epithelial cells and contrast of mRNA expression level of SFRPI in 
transgenic- epithelial and –stromal cells both isolated from PE-PTEN+/-IKK2ca/ca 
lateral prostates. ##############################################################################################################################################%%!
Figure 33: Comparison of mRNA expression level of SFRP IV in transgenic epithelial 
cells isolated from PE-PTEN+/-IKK2ca/ca lateral prostates to non- transgenic 
(wildtype) epithelial cells and contrast of mRNA expression level of SFRP IV in 
transgenic- epithelial and –stromal cells both isolated from PE-PTEN+/-IKK2ca/ca 
lateral prostates. ##############################################################################################################################################%&!
Figure 34: mRNA expression level of inflammatory cytokine TNF! in epithelial cell 
line treated with mock control or BMS-345541 for 72 hours.###################################################%'!
Figure 35: mRNA expression level of inflammatory chemokine CXCL5 in epithelial 
cell line treated with mock control or BMS-345541 for 72 hours. ##########################################%(!
Figure 36: Immunoblot analysis from protein isolates of transgenic prostate tissue 
and wildtype targeting Nkx3.1.#################################################################################################################%*!
Figure 37: Immunoblot Analysis from transgenic explant cell cultures of transgenic 
prostate tissue showing protein level of IkB!. "-Tubulin was used as 
housekeepinggene. #######################################################################################################################################&+!
Figure 38: Immunoblot analysis from transgenic explant cell cultures of transgenic 
prostate tissue showing protein level of IkB! in AP; DP and LP of PE-PTEN 
IKK2ca/ca in comparison to wildtype prostate cells. "-Tubulin was used as 
housekeeping gene. ######################################################################################################################################&+!
Figure 39: Anti Flag stain in PE-IKK2ca/ca and wildtype mice31.##########################################&$!
Figure 40: paraffin sections of lateral prostates (12months) stained for proliferation 
marker Ki67. Positive epithelial cells (arrowhead) and stromal cells (arrow) were 
seen31. ##################################################################################################################################################################&%!
Figure 41: Antibodystaining of cryosecions from dorsal prostates of PE-PTEN+/-
IKK2ca/ca mice using CD11b, F4/80 and Gr-1 antibodies31. ##################################################&'!
Figure 42: Paraffin sections of lateral prostates (12months) stained for Androgen 
Receptor (AR). Same tissues were stained for Hoechst to indicate tissue structure31.##################################################################################################################################################################################&(!
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5.3  Summary 
Prostate cancer is one of the most common cancer types in man all over the world. In 
former investigations it was shown that genetic as well as epigenetic factors could be 
involved in prostate cancer progression. It was also shown that bacterial and viral 
infections could trigger inflammation, which later could lead to an increase in tumor 
formation. Noticeable is that there seems to be a correlation between inflammation 
and tumor formation at a later time point. 
In our studies we wanted to investigate this correlation using a mouse model 
expressing a constitutively active IkB kinase (IKK2) in epithelial cells of the mouse 
prostate. IKK2 is a component of the NFkB pathway and is involved in triggering 
immune responses activated by several stimuli. However, overexpression of this 
protein is not sufficient to induce prostate cancer formation or even changes in 
prostate tissue. But constitutive active IKK2 kinase in combination with heterozygote 
loss of phosphatase and tensin homologe (PTEN) in the same cell type, leads to an 
increase of tumor size in epithelial and stromal proliferation in prostate tissue.  
Starting with microarray analysis we revealed several up and down regulated genes 
that were later investigated using real time RT PCR, immunoblot and 
immunohistochemical analysis. We could show a clear infiltration of immune cells into 
the prostate tissue, mainly macrophages/monocytes and neutrophils attracted by 
several chemokines. This inflammatory phenotype is accompanied by hyperplastic 
and dysplastic lesions but without invasive character. 
Furthermore we could reveal the downregulation of smooth muscle cell markers, 
known to be lost in invasive tumors, correlating with inflammation around many 
prostatic ducts. In our mouse model the invasive character is lacking, reason could 
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be the genetic background because C57BL/6 is known to have a low tumor tendency. 
Anyway this mouse model shows how inflammation in combination with genetic 
mutations could lead to tumor formation in time. 
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5.4  Zusammenfassung 
Prostatakrebs ist in der männlichen Bevölkerung die häufigste Krebsart und es 
herrscht reges Interesse die Hintergründe und Ursachen dieser Krankheit 
aufzudecken. Unlängst haben Forschungen ergeben, dass die vermutlich 
ausschlaggebende Komponente zur Entstehung von Prostatakrebs in der Genetik 
und Epigenetik zu suchen ist.  
Weiters wurde gezeigt, dass auch bakterielle und virale Infektionen Entzündungen 
auslösen können, die in weiterer Folge in Verdacht stehen in chronischer Form 
krebsauslösend zu sein. Es scheint also einen Zusammenhang zwischen lange 
andauernden Entzündungen und Prostatakrebs zu geben.  
In diesem Projekt haben wir versucht dieser These nachzugehen indem wir auf der 
einen Seite mit einem Mausmodel (PE-IKK2ca/ca) gearbeitet haben, das eine 
konstitutiv aktive Form der Kinase IKK2 in Prostata Epithelzellen exprimiert. IKK2 ist 
eine Kinase im so genannten NFkB pathway die maßgeblich an immunologischen 
Prozessen, aktiviert durch eine Vielzahl von Stimuli, beteiligt ist. Wir konnten zeigen, 
dass die permanente entzündliche Stimulierung durch die konstitutive Aktivierung von 
IKK2 im oben angesprochenen Mausmodell nicht zu wesentlichen Veränderungen 
des Prostatagewebes führt. Des weiteren arbeiteten wir mit einem doppelt 
transgenen Mausmodell (PE-PTEN IKK2ca/ca), das ebenfalls die konstitutiv aktive 
Form der Kinase IKK2 in Prostata Epithelzellen exprimiert, aber zusätzlich 
Phosphatase und Tensin homolog (PTEN) im selben Zelltyp heterozygot 
ausgeknockt hat. Hier konnten wir eine Vergrößerung des Tumorgewebes, epitheliale 
und stromale Proliferation und ein verändertes Genexpressionsprofil feststellen. 
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Beginnend mit einem Microarry Experiment konnten einige interessante hinauf und 
hinunter regulierte Gene detektiert werden auf die wir in real-time RT-PCR 
Experimenten, Immunoblot-Analysen und histologischen Stainings näher 
eingegangen sind. Es konnte eine stark erhöhte Immunzellinfiltrierung, hauptsächlich 
Makrophagen/Monozyten und Neutrophile, des Prostatagewebes die vermutlich 
durch eine erhöhte Anzahl von Chemokinen angelockt wurden, nachgewiesen 
werden. Doppelt transgene Mäuse zeigten des weiteren einen Prostata Phenotyp der 
durch Hyperplasie und dysplastisches Gewebe, das jedoch keinen invasiven 
Charakter zeigt, gezeichnet ist.  
Interessanterweise sind Faktoren wie zum Beispiel Gene spezifisch für Zellen der 
glatten Muskulatur, die bei der Formation von invasiven Tumoren verloren gehen, 
stark herunterreguliert. Dennoch fehlt der invasive Charakter, was eventuell durch 
den C57BL/6 Background zu begründen ist, der dafür bekannt ist, eine niedrige 
Tumortendenz zu haben. 
Nichts desto trotz stellt dieses Mausmodell ein interessantes Objekt dar, um 
Veränderungen im Prostatagewebe, herbeigeführt durch chronische Entzündung und 
die heterozygote Mutation von PTEN, zu erforschen. Gegebenenfalls könnte es bei 
einer Langzeitstudie, herbeigeführt durch weitere Genmutationen, in diesem 
Mausmodell zur Karzinomausbildung kommen. 
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